Skip to main content
. 2018 Feb 20;6:37. doi: 10.1186/s40168-018-0414-7

Table 2.

Selected target genes

Category Target
ampC resistances ACC; ACT/MIR; ampC; BIL/LAT/CMY; DHA; FOX; MOX/CMY
Carbapenem resistance IMP-1 group; IMP-16; IMP-2 group; IMP-7; KPC; NDM; OXA-23; OXA-40; OXA-48; OXA-58; OXA-72; VIM
Extended-spectrum beta-lactamase CTX-M group 1; CTX-M group 2; CTX-M group 8/25; CTX-M group 9; GES; OXA-1; PER-1; PER-2; SHV; TEM; VEB
Macrolide resistance ErmA; ErmB, mefE
Quinolone and fluoroquinolone resistance QnrA; QnrB
Vancomycin resistance vanA1; vanA2; vanB; vanC1; vanC2-C3-1; vanC2-C3-2
Endogenous control 16S (bacterial); GAPDH (human)
Inhibition control, exogenous exoIPC
Species-specific genes ACICU_00593 (Acinetobacter baumannii); femA SA (Staphylococcus aureus); femA SE (Staphylococcus epidermidis)
HHS Vulnerability Disclosure